Compound heterozygosity for a frameshift mutation and an upstream deletion that reduces expression of SERPINH1 in siblings with a moderate form of osteogenesis imperfecta.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
08 2019
Historique:
received: 22 10 2018
revised: 13 02 2019
accepted: 15 04 2019
pubmed: 11 6 2019
medline: 4 8 2020
entrez: 11 6 2019
Statut: ppublish

Résumé

SERPINH1 encodes the collagen chaperone HSP47 that binds to arginine-rich sequences in the type I procollagen trimers and provides the final steps in the folding and stabilization of the triple helical domain. Loss of both alleles in mice results in very early embryonic lethality. SERPINH1 mutations have been associated with one of the rarest forms of recessively inherited osteogenesis imperfecta (OI) with a moderate to severe phenotype. We identified a family with non-consanguineous unaffected parents who had two children with moderate short stature, low bone density, and fractures. Both children were compound heterozygotes for two mutations: a frameshift in the last exon that deleted the RER retention signal, and a 5,274 bp deletion 2.37 kb upstream from the transcription start site. The maternally-inherited frameshift allele was expressed at normal levels, but the protein was unstable. The mRNA encoded by the second allele represented about 50% of that from the frameshift-containing allele. The upstream deletion was inherited from the father, and the mRNA encoded by that allele in his cultured dermal fibroblasts was also expressed at a low level, which confirmed that this domain had a regulatory function for SERPINH1. Regulatory mutations are uncommon causes of human genetic disorders, and the ability to measure expression levels in appropriate cells is key to their identification.

Identifiants

pubmed: 31179625
doi: 10.1002/ajmg.a.61170
doi:

Substances chimiques

COL1A2 protein, human 0
Collagen Type I 0
Collagen Type I, alpha 1 Chain 0
HSP47 Heat-Shock Proteins 0
SERPINH1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1466-1475

Subventions

Organisme : Department of Pathology
Pays : International
Organisme : University of Washington
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Ulrike Schwarze (U)

Department of Pathology, University of Washington, Seattle, Washington.

Tim Cundy (T)

Department of Medicine, Faculty of Medical & Health Sciences, University of Auckland, New Zealand.

Yajuan J Liu (YJ)

Department of Pathology, University of Washington, Seattle, Washington.

Paul L Hofman (PL)

Liggins Institute, Faculty of Medical & Health Sciences, University of Auckland, New Zealand.

Peter H Byers (PH)

Department of Pathology, University of Washington, Seattle, Washington.
Department of Medicine (Medical Genetics), University of Washington, Seattle, Washington.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH